Paper37257500
Ferroptosis Signaling Pathways: Alzheimer's Disease.
Maheshwari S. Horm Metab Res, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Ferroptosis Signaling Pathways: Alzheimer's Disease. Papers, record 37257500. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37257500
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Alzheimer Disease | Major topic |
| Humans | |
| Lipid Peroxidation | |
| Iron | |
| Fatty Acids, Unsaturated | |
| Signal Transduction |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797432 | Two-Dimensional MXene-Loaded Butylphthalide Enhances the Treatment of Alzheimer's Disease by Inhibiting Ferroptosis and Oxidative Stress. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797432 | PubMed |
| 42491041 | Histone lactylation-mediated glycolysis-ferroptosis axis in neurological diseases. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42491041 | PubMed |
| 42073997 | Impact of Oxidative Stress-Driven Ferroptosis in Neurodegeneration. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42073997 | PubMed |
| 41738060 | Ferroptosis in Cerebral Ischemia/Reperfusion Injury: Mechanistic Drivers and Therapeutic Frontiers. | Neuropsychiatr Dis Treat | 2026 | https://conductscience.org/library/papers/41738060 | PubMed |
| 41624205 | Modified Sanjia Powder ameliorates cognitive impairment and exerts neuroprotective effects in 5 × FAD mice: insights from quantitative proteomics. | Front Nutr | 2025 | https://conductscience.org/library/papers/41624205 | PubMed |
| 41301782 | Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer's Disease Using CSF Erythrocyte Load and Clinical Data. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301782 | PubMed |
| 41156228 | From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer's Disease. | J Clin Med | 2025 | https://conductscience.org/library/papers/41156228 | PubMed |
| 40867878 | New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867878 | PubMed |
| 40661149 | Ferroptosis in neurodegenerative diseases: potential mechanisms of exercise intervention. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40661149 | PubMed |
| 40559667 | Targeting Ferroptosis in Tumors: Novel Marine-Derived Compounds as Regulators of Lipid Peroxidation and GPX4 Signaling. | Mar Drugs | 2025 | https://conductscience.org/library/papers/40559667 | PubMed |
| 40428318 | Development and Experimental Validation of Machine Learning-Based Disulfidptosis-Related Ferroptosis Biomarkers in Inflammatory Bowel Disease. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40428318 | PubMed |
| 40100417 | Targeting ferroptosis for the treatment of female reproductive system disorders. | J Mol Med (Berl) | 2025 | https://conductscience.org/library/papers/40100417 | PubMed |
| 40066336 | Ferroptosis, pathogenesis and therapy in AS co-depression disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40066336 | PubMed |
| 39717848 | The role of ferroptosis-related non-coding RNA in liver fibrosis. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39717848 | PubMed |
| 38984029 | Advancements in understanding the role of ferroptosis in hypoxia-associated brain injury: a narrative review. | Transl Pediatr | 2024 | https://conductscience.org/library/papers/38984029 | PubMed |
| 38069073 | Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069073 | PubMed |
| 37513928 | The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37513928 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACSL4 | 2182 | PubTator's text mining | https://conductscience.org/library/genes/2182 | NCBI Gene |
| LPCAT3 | 10162 | PubTator's text mining | https://conductscience.org/library/genes/10162 | NCBI Gene |
| POR | 5447 | PubTator's text mining | https://conductscience.org/library/genes/5447 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37257500
GET https://conductscience.org/api/papers/v1/37257500/authors